Lktime Biotechnology Co., Ltd. (“Lktime Biotech” for short) is a high-tech enterprise specializing in biologics CDMO services which was established in June 2021. The company has established R&D and pilot-scale platforms in Fengxian Lingang and Zhangjiang, Shanghai, and commercial production bases in Cuiheng New District of Zhongshan City and Changchun Beihu Science and Technology Development Zone.

Lktime Biotech especially develops a leading domestic and foreign biologics CDMO service platform, aiming to provide biological products innovative enterprises with services including druggability evaluation, high-quality early pharmacological and toxicological research sample production, production process development, clinical application support services, clinical sample production and commercial production based on two major platforms (mammalian cell expression platform and microbial expression platform).

Lktime Biotech can accelerate the pre-clinical development of biological products, improve the quality of biological products and reduce production costs for our customers with our one-stop CDMO service. This allows our customers to launch better quality and more affordable biopharmaceuticals as soon as possible!